208 related articles for article (PubMed ID: 18532912)
1. High-throughput proteomics of breast carcinoma cells: a focus on FTICR-MS.
Umar A; Jaremko M; Burgers PC; Luider TM; Foekens JA; Pasa-Tolic L
Expert Rev Proteomics; 2008 Jun; 5(3):445-55. PubMed ID: 18532912
[TBL] [Abstract][Full Text] [Related]
2. Comparison of indirect and direct approaches using ion-trap and Fourier transform ion cyclotron resonance mass spectrometry for exploring viperid venom proteomes.
Fox JW; Ma L; Nelson K; Sherman NE; Serrano SM
Toxicon; 2006 May; 47(6):700-14. PubMed ID: 16574175
[TBL] [Abstract][Full Text] [Related]
3. Proteome analysis of Escherichia coli using high-performance liquid chromatography and Fourier transform ion cyclotron resonance mass spectrometry.
Ihling C; Sinz A
Proteomics; 2005 May; 5(8):2029-42. PubMed ID: 15852340
[TBL] [Abstract][Full Text] [Related]
4. Top-down proteomics on a high-field Fourier transform ion cyclotron resonance mass spectrometer.
Ouvry-Patat SA; Torres MP; Gelfand CA; Quek HH; Easterling M; Speir JP; Borchers CH
Methods Mol Biol; 2009; 492():215-31. PubMed ID: 19241035
[TBL] [Abstract][Full Text] [Related]
5. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
6. FTICR mass spectrometry for qualitative and quantitative bioanalyses.
Page JS; Masselon CD; Smith RD
Curr Opin Biotechnol; 2004 Feb; 15(1):3-11. PubMed ID: 15102459
[TBL] [Abstract][Full Text] [Related]
7. The interface of capillary electrophoresis with high performance Fourier transform ion cyclotron resonance mass spectrometry for biomolecule characterization.
Severs JC; Hofstadler SA; Zhao Z; Senh RT; Smith RD
Electrophoresis; 1996 Dec; 17(12):1808-17. PubMed ID: 9034761
[TBL] [Abstract][Full Text] [Related]
8. Analysis of nucleic acids by FTICR MS.
Hofstadler SA; Sannes-Lowery KA; Hannis JC
Mass Spectrom Rev; 2005; 24(2):265-85. PubMed ID: 15389854
[TBL] [Abstract][Full Text] [Related]
9. FTICR mass spectrometry in proteomics.
Bergquist J
Curr Opin Mol Ther; 2003 Jun; 5(3):310-4. PubMed ID: 12870442
[TBL] [Abstract][Full Text] [Related]
10. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
11. Electrospray ionisation Fourier-transform ion cyclotron resonance mass spectrometry of dynamic combinatorial libraries.
Poulsen SA; Gates PJ; Cousins GR; Sanders JK
Rapid Commun Mass Spectrom; 2000; 14(1):44-8. PubMed ID: 10623927
[TBL] [Abstract][Full Text] [Related]
12. Optimal pressure conditions for unbiased external ion accumulation in a two-dimensional radio-frequency quadrupole for Fourier transform ion cyclotron resonance mass spectrometry.
Belov ME; Gorshkov MV; Alving K; Smith RD
Rapid Commun Mass Spectrom; 2001; 15(21):1988-96. PubMed ID: 11675664
[TBL] [Abstract][Full Text] [Related]
13. Rapid quantitative measurements of proteomes by Fourier transform ion cyclotron resonance mass spectrometry.
Smith RD; Pasa-Tolić L; Lipton MS; Jensen PK; Anderson GA; Shen Y; Conrads TP; Udseth HR; Harkewicz R; Belov ME; Masselon C; Veenstra TD
Electrophoresis; 2001 May; 22(9):1652-68. PubMed ID: 11425221
[TBL] [Abstract][Full Text] [Related]
14. NanoLC-FT-ICR MS improves proteome coverage attainable for approximately 3000 laser-microdissected breast carcinoma cells.
Umar A; Luider TM; Foekens JA; Pasa-Tolić L
Proteomics; 2007 Jan; 7(2):323-9. PubMed ID: 17163580
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
16. Free-flow electrophoresis for top-down proteomics by Fourier transform ion cyclotron resonance mass spectrometry.
Ouvry-Patat SA; Torres MP; Quek HH; Gelfand CA; O'Mullan P; Nissum M; Schroeder GK; Han J; Elliott M; Dryhurst D; Ausio J; Wolfenden R; Borchers CH
Proteomics; 2008 Jul; 8(14):2798-808. PubMed ID: 18655049
[TBL] [Abstract][Full Text] [Related]
17. Advanced nanoscale separations and mass spectrometry for sensitive high-throughput proteomics.
Shen Y; Smith RD
Expert Rev Proteomics; 2005 Jun; 2(3):431-47. PubMed ID: 16000088
[TBL] [Abstract][Full Text] [Related]
18. A high-resolution scanning microprobe matrix-assisted laser desorption/ionization ion source for imaging analysis on an ion trap/Fourier transform ion cyclotron resonance mass spectrometer.
Koestler M; Kirsch D; Hester A; Leisner A; Guenther S; Spengler B
Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3275-85. PubMed ID: 18819119
[TBL] [Abstract][Full Text] [Related]
19. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
20. Separation of R-form lipopolysaccharide and lipid A by CE-Fourier-transform ion cyclotron resonance MS.
Hübner G; Lindner B
Electrophoresis; 2009 May; 30(10):1808-16. PubMed ID: 19441031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
